Civic Intelligence

Neuromuscular Study Group Inc.

990 • Fiscal year 2023 • EIN 47-4456205

Jan 01, 2023 to Dec 31, 2023

Organization Profile
Kansas City, KS
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

64th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2023 filings • 501(c)3 • <$500k nonprofits • Source year 2023

Liabilities / Revenue

63rd percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2023 filings • 501(c)3 • <$500k nonprofits • Source year 2023

Net Margin

32nd percentile

-6.5%

Higher net margin than 32% of similar nonprofits.

2023 filings • 501(c)3 • <$500k nonprofits • Source year 2023

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2023

Asset Growth

36th percentile

-5.7%

Faster asset growth than 36% of similar nonprofits.

2023 filings • 501(c)3 • <$500k nonprofits • Annualized from 2022 to 2023

Revenue Growth

83rd percentile

56%

Faster revenue growth than 83% of similar nonprofits.

2023 filings • 501(c)3 • <$500k nonprofits • Annualized from 2022 to 2023

Balance Sheet
Liabilities / Assets64th percentile

Assets

Down

$460,644

Down $28,049 (-5.7%) from 2022

Net Assets

Down

$460,644

Down $28,049 (-5.7%) from 2022

Liabilities

Flat

$0

Flat from 2022

Revenue And Expenses
Liabilities / Revenue63rd percentileNet Margin32nd percentile

Revenue

Up

$434,016

Up $155,411 (+56%) from 2022

Expenses

Up

$462,062

Up $36,145 (+8.5%) from 2022

Net Income

Up

-$28,046

Up $119,266 (+81%) from 2022

Historical Trend

Balance Sheet Trend

Asset Growth36th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$800K$600K$400K$200K$0Assets 2015: $1Liabilities 2015: $02015Assets 2016: $32,371Liabilities 2016: $0Net Assets 2016: $32,3712016Assets 2017: $77,285Liabilities 2017: $0Net Assets 2017: $77,2852017Assets 2018: $182,899Liabilities 2018: $0Net Assets 2018: $182,8992018Assets 2019: $272,554Liabilities 2019: $0Net Assets 2019: $272,5542019Assets 2020: $400,026Liabilities 2020: $0Net Assets 2020: $400,0262020Assets 2021: $636,005Liabilities 2021: $0Net Assets 2021: $636,0052021Assets 2022: $488,693Liabilities 2022: $0Net Assets 2022: $488,6932022Assets 2023: $460,644Liabilities 2023: $0Net Assets 2023: $460,6442023Assets 2024: $530,512Liabilities 2024: $0Net Assets 2024: $530,5122024

Highlighted filing

2023

Assets$460,644
Liabilities$0
Net Assets$460,644
Open 2023 Filing

Operations Trend

Revenue Growth83rd percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$600K$400K$200K$0-$200KRevenue 2015: $0Expenses 2015: $0Net Income 2015: $02015Revenue 2016: $213,854Expenses 2016: $181,483Net Income 2016: $32,3712016Revenue 2017: $254,954Expenses 2017: $210,040Net Income 2017: $44,9142017Revenue 2018: $350,603Expenses 2018: $244,989Net Income 2018: $105,6142018Revenue 2019: $461,043Expenses 2019: $371,388Net Income 2019: $89,6552019Revenue 2020: $284,473Expenses 2020: $157,001Net Income 2020: $127,4722020Revenue 2021: $428,433Expenses 2021: $192,454Net Income 2021: $235,9792021Revenue 2022: $278,605Expenses 2022: $425,917Net Income 2022: -$147,3122022Revenue 2023: $434,016Expenses 2023: $462,062Net Income 2023: -$28,0462023Revenue 2024: $588,959Expenses 2024: $519,092Net Income 2024: $69,8672024

Highlighted filing

2023

Revenue$434,016
Expenses$462,062
Net Income-$28,046
Open 2023 Filing
Filing Detail Status

This 2023 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

View Latest Detailed Filing (2024)
Jump To
Filing Snapshot
Filing Period
Jan 1, 2023 to Dec 31, 2023
Mission and Program Overview

Mission

To advance knowledge about the cause(s), pathogenesis, epidemiology, and clinical manifestations of muscle disease and related neuromuscular disorders and to develop and implement strategies to examine promising therapeutic interventions.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2023 • Form 990Summary only. Only limited summary data is available for this year.

Open filing
Assets
$460,644
Liabilities
$0
Net assets
$460,644
Revenue
$434,016
Expenses
$462,062
Net income
-$28,046
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Facts available. Structured filing facts are available, but richer extracted sections are limited.$5.31$0.00$5.31$5.89$5.19$0.70
2023Summary only. Only limited summary data is available for this year.$4.61$0.00$4.61$4.34$4.62$0.28
2022XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$4.89$0.00$4.89$2.79$4.26$1.47
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$6.36$0.00$6.36$4.28$1.92$2.36
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$4.00$0.00$4.00$2.84$1.57$1.27
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$2.73$0.00$2.73$4.61$3.71$0.90
2018Summary only. Only limited summary data is available for this year.$1.83$0.00$1.83$3.51$2.45$1.06
2017Summary only. Only limited summary data is available for this year.$0.77$0.00$0.77$2.55$2.10$0.45
2016Summary only. Only limited summary data is available for this year.$0.32$0.00$0.32$2.14$1.81$0.32
2015Summary only. Only limited summary data is available for this year.$0.00$0.00$0.00$0.00$0.00
Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. 2023 filings • 501(c)3 • <$500k nonprofits